Biktarvy, or bictegravir/emtricitabine/tenofovir alafenamide, is a powerful and well-established single-tablet regimen used to control HIV infection. It's a integrated medication combining bictegravir, emtricitabine, and tenofovir alafenamide, working together to inhibit viral replication. Generally, Biktarvy offers a convenient way for individuals